NCT05813925: A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
- State
- Completed
- Phase
- Phase 3
- People
- 331 taking part
- Started
- 3 Apr 2023
- Primary completion
- 17 Jan 2025
- Arms
- CagriSema 2.4 mg/2.4 mg
- Results
- None posted
- 3 Apr 2023: Trial started
- 14 Apr 2023: Trial registered
- 7 Mar 2025: Trial completed